Santiago de Compostela, Aug 2, 2021.
The adoption of Mnova software comes on the heels of a major expansion of chemistry at NovAliX with the acquisition of a state-of-the art R&D facility in Val-de-Reuil (Normandy, France). In addition, this nuclear magnetic resonance spectrum-processing software will be used in all NovAliX research centers.
Julien Marin, Business Unit Director, Chemistry at NovAliX said: “The automatic conversion of spectra to patent format in a single click is a massive time-saver for our chemists. On the other hand, as part of the extension of our DNA-encoded library platform, NovA-DEL, we are collaborating with Mestrelab to robotize the analysis of mass spectra using Mnova Gears software to boost the productivity of our already highly automated platform.”
Founded in 2002 and based in Strasbourg, France, NovAliX is a drug discovery-focused CRO with several unique technologies. It employs 200 researchers, with capabilities that combine chemistry and biophysics. NovAliX offers its clients original collaborative models and extensive services within the framework of research programs dedicated to drug discovery. Its ambition is to continue its development by both strengthening its internationalization and extending and integrating the new capabilities essential to the success of its clients' therapeutic research projects into its technologies and base of expertise.
For more information: www.novalix.com
Guy Desmarquets, Senior Vice President, Global Sales & Strategic Partnership at Mestrelab Research, said: “We are delighted to report the choice of NovAliX in our technology, providing a set of software tools perfectly adjusted to its end-users needs and multi-site environments. We are also very excited to start a collaboration around DNA encoded libraries. We see a synergy between the development of NovAliX in the pharmaceutical and biotechnological domain and our efforts to provide processing and automation capabilities to this market."
About Mestrelab Research
Mestrelab is based in Santiago de Compostela, Spain, and it has direct scientific software sales and support capabilities throughout Europe and North America, and experienced software distributors in Japan, China, and many other countries. Mestrelab was founded in 2004, and today has approximately 40 employees developing software for over 3,000 pharmaceutical, chemical industry, and academic customers, with more than 100,000 user software licenses deployed worldwide. Mestrelab is an agile and experienced developer of advanced software solutions and tools for the pharmaceutical, analytical, and scientific research community to enhance the management and understanding of chemistry information.
For more information: www.mestrelab.com